Defective post–thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosi

Author:  ["Jorge Correale","Wendy Gilmore","Jerome Lopez","Si Q. Li","Minnie McMillan","Leslie P. Weiner"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

We have recently isolated a panel of T–cell clones from chronic progressive multiple sclerosis (MS) patients that are capable of functioning as antigen–presenting cells and of expressing the costimulatory molecules B7–1 and B7–2. In this report we show that these T–cell clones are resistant to inhibitory regulation, including the induction of anergy and sensitivity to tumor growth factor–β (TGF–β)–induced growth inhibition. The resistance to anergy induction was associated with expression of B7 costimulatory molecules. These data suggest that lack of responsiveness to peripheral inhibitory signals may account for the entry of autoimmune diseases into a chronic progressive phase.

Cite this article

Correale, J., Gilmore, W., Lopez, J. et al. Defective post–thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosis. Nat Med 2, 1354–1360 (1996). https://doi.org/10.1038/nm1296-1354

View full text

>> Full Text:   Defective post–thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosi

Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft surviva

Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone ma